Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster session 09

554P - Does the type of hysterectomy affect the survival of patients with clinical IA endometrial cancer: A multicenter and retrospective study

Date

10 Sep 2022

Session

Poster session 09

Topics

Tumour Site

Endometrial Cancer

Presenters

Chenmian Liu

Citation

Annals of Oncology (2022) 33 (suppl_7): S235-S282. 10.1016/annonc/annonc1054

Authors

C. Liu1, K. Song2, R. Chu2

Author affiliations

  • 1 Department Of Gynaecology And Obstetrics, Qilu Hospital of Shandong University, 250012 - Jinan/CN
  • 2 Department Of Obstetrics And Gynecology, Qilu Hospital of Shandong University, 250012 - Jinan/CN

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 554P

Background

Endometrial cancer (EC) is the most frequent gynecological malignancy, and most patients (75%) are diagnosed at an early stage. Surgeons need more reliable evidence to choose the appropriate hysterectomy type for patients with early-stage EC.

Methods

Patients with clinical stage IA endometrial carcinoma who underwent hysterectomy between January 2000 and December 2018 were included from six medical centers. Subsequently, 1:1 propensity-score matching was performed between type A hysterectomy (simple total hysterectomy) and type B/C hysterectomy (modified or radical hysterectomy). Disease-free survival (DFS) and overall survival (OS) were assessed using Kaplan–Meier curves. Cox proportional hazards regression analysis was used to analyze the risk factors for DFS.

Results

A total of 1057 patients were included, of which 960 (92.6%) underwent type A hysterectomy and 97 (9.4%) underwent type B/C hysterectomy. Patients in the type B/C group showed greater estimated blood loss (median 200 vs. 120 mL, P < 0.001), longer postoperative hospital stays (median 19 vs. 11 days, P < 0.001), and more postoperative complications (6.2% vs. 2.0%, P = 0.009). The two groups showed no significant differences in DFS and OS before and after matching (P > 0.05). Multivariate Cox analysis revealed that cervical involvement and lymph node metastasis were prognostic factors for survival.

Conclusions

Radical or modified radical hysterectomy did not affect the clinical prognosis of patients with clinical stage IA endometrial carcinoma. However, these procedures could result in greater blood loss, more postoperative complications, and longer hospital stays. The choice of radical hysterectomy needs to be carefully considered in clinical practice.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Taishan Scholar Youth Project of Shandong Province (grant number tsqn201812130).

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.